Schedule 13D ownership disclosure

PASITHEA THERAPEUTICS CORP

Common Stock, par value $0.0001 per share · CUSIP: 70261F202

Event date: 2025-03-01

Filing-level shares
83,858.00
Percent of class
3.1%
  • Lawrence SteinmanReported CIK 0001132679

    Shares: 83,858.00 · Class: 3.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013762-25-000233
Form type
SCHEDULE 13D/A
Filer
Pasithea Therapeutics Corp.
CIK
CIK 1841330
Filed
Mar 06, 2025
Reporting period
Mar 01, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub